null Skip to main content
In-Vitro Research Only
Sign in

Scientific Analysis of MOTS-c: Mitochondrial-Derived Peptide Research

Compliance & Laboratory Safety Team26th Jun 2026

Fluorescent stained in-vitro cell cultures glowing under UV light, highlighting cellular structures and mitochondria in a laboratory setting.

Cellular biology increasingly recognises mitochondria not merely as metabolic engines, but as active signalling hubs communicating stress status directly to the nucleus. This retrograde signalling pathway relies on mitochondrial-derived peptides (MDPs) encoded within the organelle's own genome. Among these compounds, MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) remains a primary subject of in-vitro investigation. First identified in 2015, this 16-amino-acid sequence regulates cellular energy states and adaptive stress responses in controlled assays. Unlike nuclear-encoded segments, MOTS-c undergoes mitochondrial transcription before translocating to the nucleus during induced metabolic stress, interacting with nuclear DNA to modulate gene expression. This analysis examines the chemical structure, molecular mechanisms, and laboratory applications of MOTS-c across the United Kingdom research sector.

VERIFIED RESEARCH REAGENT

mots-C

HPLC-verified lyophilised compound, UK-domestic supply. Manufactured under controlled conditions for qualified in-vitro laboratory research.

View Reagent Profile ›

Maintaining cellular stability under fluctuating environmental conditions requires constant mitochondrial-nuclear communication. Early biological research primarily examined anterograde signalling, where nuclear-encoded proteins import into the mitochondria. The isolation of MOTS-c highlighted retrograde signalling, proving the mitochondrion actively alters nuclear gene expression. Under induced challenges, such as glucose deprivation or oxidative stress in cellular models, MOTS-c translocates from the cytoplasm to the nucleus. Active transport mechanisms facilitate this movement, a process currently under characterisation in continuous cell lines. Once inside the nucleus, the peptide binds to specific transcription factors, regulating genes involved in nutrient sensing and cellular defence.

MOTS-c comprises a 16-amino-acid sequence: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg, yielding a molecular weight of approximately 2174.7 Da. The mitochondrial 12S ribosomal RNA gene encodes this sequence, occupying a region formerly believed to lack protein-coding capacity. Because of its alternating hydrophobic and hydrophilic regions, synthesising this peptide requires strict environmental controls. Laboratory studies depend on high-purity synthetic MOTS-c, typically manufactured through solid-phase peptide synthesis (SPPS). Investigators verify compound purity using high-performance liquid chromatography (HPLC) and mass spectrometry (MS), ensuring synthetic impurities do not confound assay readouts. The structural integrity of MOTS-c displays high sensitivity to temperature and pH fluctuations, demanding stable conditions during storage and reconstitution to maintain reproducible data.

At the cellular level, MOTS-c acts as an endocrine-like signalling molecule coordinating metabolic adaptation. Assays demonstrate its primary mechanism involves adenosine monophosphate-activated protein kinase (AMPK) pathway activation. Introducing MOTS-c to cell cultures promotes the accumulation of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), an intermediate in the purine nucleotide synthesis pathway that triggers AMPK. This activation initiates downstream cellular events, including elevated glucose uptake via GLUT4 translocation and accelerated fatty acid beta-oxidation. In addition to these cytoplasmic effects, metabolic stressors like nutrient deprivation force MOTS-c into the nucleus. Here, it binds to promoter regions and regulates transcription for genes linked to antioxidant defence, including the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway. This dual capacity makes the compound highly relevant for researchers analysing cellular resilience.

Methodology Brief: Analytical characterisation of MOTS-c in laboratory settings requires a combination of reversed-phase high-performance liquid chromatography to assess purity and matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry to confirm molecular weight. These quality control steps ensure that the synthetic peptide matches the native mitochondrial sequence without truncation or side-product contamination.

Key Takeaways for MOTS-c Research

  • Mitochondrial Origin: The mitochondrial 12S rRNA gene encodes MOTS-c, making it a vital component of retrograde mitochondrial-nuclear signalling.
  • AMPK Activation: The peptide stimulates the AMPK pathway via AICAR accumulation, directing cellular energy balance in-vitro.
  • Nuclear Translocation: Under induced metabolic stress, MOTS-c translocates to the nucleus to regulate transcription factors like Nrf2.
  • Strictly Research-Grade: The compound remains reserved exclusively for in-vitro laboratory evaluation and lacks approval for human consumption.

For experimental use, suppliers provide MOTS-c as a lyophilised powder. Technicians must perform reconstitution under sterile conditions using a bacteriostatic solvent designed to preserve peptide stability and prevent microbial proliferation. Solvent selection remains critical; improper pH or ionic strength initiates peptide aggregation or rapid degradation. Upon reconstitution, laboratories should aliquot the solution into single-use vials to avoid repeated freeze-thaw cycles, which degrade the peptide's secondary structure. Vials require storage at -20°C or lower, whereas unconstituted lyophilised batches tolerate 4°C for short durations. Investigators must avoid vigorous agitation or vortexing during preparation, relying instead on gentle swirling to achieve complete dissolution.

In-vitro applications for MOTS-c span multiple branches of molecular biology. Senescence models allow researchers to examine how the peptide influences the secretory phenotype of ageing cells and its potential to mitigate oxidative stress-induced cellular damage. The compound also features prominently in metabolic dysfunction research, where assays measure insulin sensitivity and lipid accumulation across hepatocyte and adipocyte lines. By tracking glucose transporter expression in-vitro, scientists isolate the fundamental mechanisms of metabolic regulation. Additional investigations target osteoblast differentiation and cardiovascular endothelial cell survival under hypoxic conditions, mapping the broader relevance of mitochondrial signalling networks.

In-Vitro Research FAQ

Deconstructing the Fallacies: What are the primary mots-c peptide benefits claimed online versus scientific reality?

While alternative health communities frequently claim systemic "benefits", in-vitro research maintains a strictly cellular focus. Laboratory data indicates that MOTS-c regulates metabolic homeostasis and cellular stress responses in isolated environments. Assays demonstrate it enhances glucose uptake in skeletal muscle cell lines, promotes fatty acid beta-oxidation, and protects cells from oxidative stress by upregulating antioxidant enzymes. These observations strictly define its role in maintaining cellular viability during periods of metabolic deprivation, not as a therapeutic intervention.

Scientific Clarification: How is the mots-c peptide dosage determined for laboratory experiments?

It is vital to clarify that "dosage" is a medical term associated with human administration, which remains strictly outside the scope of MOTS-c research. Unregulated biohacker claims often misappropriate this terminology. In legitimate laboratory settings, researchers determine the appropriate concentration—not dosage—based on the specific cell line and experimental design. Typical in-vitro concentrations range from 10 nM to 10 µM. For animal models used in approved institutional research, scientists calculate the required volume based on weight and desired systemic exposure, utilising precise reconstitution solvent ratios to prepare working solutions.

Where can researchers secure a reliable mots-c peptide buy option for UK laboratories?

For academic and industrial laboratories seeking to acquire this compound, sourcing from a verified UK supplier is essential to guarantee purity and analytical consistency. When searching to purchase mots-c peptide uk, researchers must select vendors providing comprehensive batch analysis, including HPLC and mass spectrometry data. This ensures the compound meets the exact standards required for reproducible scientific analysis.

What standards should be verified when evaluating mots-c peptide for sale online?

When assessing mots-c peptide for sale, researchers must confirm the product is designated strictly for laboratory research and in-vitro evaluation. Reputable suppliers provide exhaustive documentation regarding peptide purity, salt content, and lyophilisation state. Securing research materials from certified sources prevents experimental anomalies caused by impurities or degraded sequences. For broader analytical requirements, laboratories may also evaluate other specialised categories, such as cosmeceutical research compounds, to support diverse experimental objectives.

Scientific References

  • Lee, C., et al. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and prevents diet-induced obesity and insulin resistance. Cell Metabolism, 21(3), 443-454. View published research
  • Kim, K. H., et al. (2018). MOTS-c peptide prevents ovariectomy-induced bone loss by stimulating osteoblastogenesis. Journal of Bone and Mineral Research, 33(10), 1872-1883. View published research
  • Reynolds, J. C., et al. (2021). MOTS-c is an exercise-induced mitochondrial-derived peptide that regulates myocardial function and physical performance. Nature Communications, 12(1), 352. View published research
  • Ramanjaneya, M., et al. (2019). MOTS-c peptide regulates adipose tissue macrophage polarization and insulin sensitivity. Journal of Endocrinology, 241(2), 149-161. View published research
  • Lu, H., et al. (2019). MOTS-c protects against myocardial ischemia/reperfusion injury via activation of the AMPK pathway. American Journal of Translational Research, 11(8), 4885-4896. View published research

⚠️ Research Use Only Disclaimer: All peptides and compounds are sold strictly for in-vitro laboratory research purposes only. Not intended for human or veterinary use, not a dietary supplement, and not approved to diagnose, treat, cure, or prevent any disease or condition. For use by qualified researchers in suitably equipped laboratory environments only. Amino Peptides Ltd operates in full compliance with UK MHRA regulations and applicable EU research chemical guidelines.